Navigation Links
Substandard and Counterfeit Antimalarial Drugs in Ghana Discovered by Cooperative Program of USP, Ghana Food and Drugs Board
Date:11/8/2010

ROCKVILLE, Md., Nov. 8, 2010 /PRNewswire-USNewswire/ -- Substandard and counterfeit versions of thirteen key antimalarial medicines were uncovered in multiple locations across Ghana by the Medicines Quality Monitoring surveillance program. Set up by the Ghana Food and Drugs Board (FDB) in collaboration with the U.S. Pharmacopeial Convention (USP) and the U.S. Agency for International Development (USAID), the program samples antimalarials across the public and private sectors. It was established in 2008 and is implemented by USP's Promoting the Quality of Medicines (PQM) initiative. USP is a scientific nonprofit organization that develops globally recognized standards for the quality of medicines. Through the PQM program, USP works in developing countries to help verify and improve the quality of medications intended to treat life-threatening neglected diseases such as malaria, HIV/AIDS and tuberculosis.

"Few people fully realize the devastation that distribution of substandard or counterfeit medications can wreak on vulnerable populations," said Stephen Opuni, M.D., chief executive officer of the FDB. "In this case some of the drugs discovered contained no active pharmaceutical ingredient, while others failed to meet required quality standards. This causes great harm in two ways: the individual patients taking the drugs get no relief, and drug-resistant strains of malaria may grow stronger. In addition, people lose confidence in the efficacy of medicines and may be reluctant to seek medical help when they need it. I'm very pleased with the outcomes we're seeing from the Medicines Quality Monitoring program."

In 2009 the same program uncovered a counterfeit version of Novartis' Coartem®, another widely used antimalarial. In that case, an alert citizen notified the authorities after suspecting the drug he bought might be fake. "Last year's seizure of counterfeit drugs showed the importance of public education," said Patrick Lukulay, Ph.D., director of the PQM program. "In the current case, rigorous surveillance worked very well. The fact that the fake and poor quality drugs were so widespread—found in many areas across Ghana, and in many types of outlets—underscores the need not only for continuing surveillance but also for active enforcement of anti-counterfeiting laws."

The discovery of the counterfeits—tragically, in use at a government-run hospital and private clinic, and being distributed through many pharmacies—has resulted in a nationwide recall of all thirteen drugs, including publicizing the names of the outlets where they were found.  This is intended as a strong deterrent, making pharmacy and hospital procurement personnel more vigilant about their suppliers. Manufacturers of some of the recalled medications will be required to meet with the FDB for required regulatory sanctions. Noted Dr. Lukulay, "It's important to keep in mind that all these fake and substandard medicines were found just in one round of post-market surveillance, just of antimalarials. The existence of many more substandard and counterfeit medications for other types of medicines and in other locations and facilities must be assumed. Public education and official collaborations between public and private sectors are both essential to protecting public health here in Ghana and in many other developing nations."

For more information about the PQM program and its work, please email mediarelations@usp.org or visit http://www.usp.org/worldwide/.

The American people, through the U.S. Agency for International Development, have provided economic and humanitarian assistance worldwide for nearly 50 years.

USP—Advancing Public Health Since 1820

The United States Pharmacopeial Convention (USP) is a scientific, nonprofit, standards-setting organization that advances public health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods. USP's standards are recognized and used worldwide. For more information about USP visit http://www.usp.org.

CONTACT: Laura Provan

301/816-8268; lnp@usp.org




'/>"/>
SOURCE U.S. Pharmacopeial Convention
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. One-Third of Antimalarial Medicines Sampled in Three African Nations Found to Be Substandard in Large-Scale USP-WHO Study
2. New Momentum Teams With Oracle to Help Reduce Counterfeiting in the Life Sciences Industry
3. Reportlinker Adds Impact of Counterfeits on Parallel Trade & Pharmaceutical Distribution: Issues, initiatives and insights for supply chain integrity
4. FDA Warns Consumers about Counterfeit Alli
5. International Operation Combats Online Supply of Counterfeit and Illegal Medicines
6. Two More Global Pharmaceutical Companies Choose New Momentum to Stop Counterfeits
7. Are the Prescription Drugs You Are Taking Real, or Counterfeit? HDNets Dan Rather Reports Investigates
8. As Pharmaceutical Supply Chain Goes Global, Threat of Counterfeiting, Intellectual Property Theft and Contamination Rises, Finds New Report; New Supply Chain Management Strategies Needed
9. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
10. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
11. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... SAN FRANCISCO , Jan. 24, 2017 /PRNewswire/ ... formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of ... In-Fusion® Cloning Primer Design Tool, powered by TeselaGen Biotechnology, ... is a unique method that seamlessly joins together linear ... free, online primer design tool facilitates easy design and ...
(Date:1/24/2017)... 2017 Sherpa Clinical Packaging ( www.sherpaclinical.com ... is pleased to announce the appointment of Kevin Rosenthal as ... Sherpa team to lead Sherpa,s Operations group and ... excellence. Kevin is not new to ... He has extensive experience working for leading pharma ...
(Date:1/24/2017)... Pa. , Jan. 24, 2017   ... 2 biopharmaceutical company developing novel therapies for the ... today announced the appointment of four world-class key ... These new appointments join QR Pharma,s previous roster ... leadership and direction to support the development of ...
Breaking Medicine Technology:
(Date:1/24/2017)... , ... January 24, 2017 , ... i2i Population Health, ... chief financial officer. , “Cary’s broad financial background is an excellent ... the strategic planning and day-to-day financial operations skills we need to take the company ...
(Date:1/24/2017)... ... January 24, 2017 , ... Twelve ... round of the 2017 Cupid's Cup Entrepreneurship Competition. Chaired by Under Armour Founder ... 2017. The entrepreneurs will showcase their businesses on February 6, 2017, at Under ...
(Date:1/24/2017)... ... , ... His message has been heard by more than 100,000 students and ... , Joel Feldman, has reached his biggest national audience yet: the three million daily ... newspapers in circulation in the country, and he hopes it will help spread his ...
(Date:1/24/2017)... ... January 24, 2017 , ... Providing solutions to critical economic ... the Frank Hawkins Kenan Institute of Private Enterprise at the University ... makers identified concrete solutions at the “What’s Next, America?” conference at the Kenan ...
(Date:1/24/2017)... ... January 24, 2017 , ... The NewKILO JRP, a ... (NMIs) and co-funded by the European Union (EU), was completed in May 2015. The ... instead being maintained and used in air, which presents some challenges to establishing traceability ...
Breaking Medicine News(10 mins):